FDA clears Abbott’s Gallant devices for cardiac arrhythmia
Abbott has received the US Food and Drug Administration (FDA) approval for its Gallant implantable cardioverter-defibrillator (ICD) and cardiac resynchronisation therapy defibrillator (CRT-D) devices.
COVID-19 fears affect appointments for routine doctor visits: Poll
The COVID-19 pandemic has dramatically reduced the number of routine outpatient visits made by people for fear of contracting the disease.
Public reluctant to visit hospitals during COVID-19 emergency: Poll
The COVID-19 pandemic has created a sense of fear among the general public in visiting hospitals, as witnessed in the responses to a recent poll conducted by Verdict.
FDA grants breakthrough status to Thermedical for SERF ablation system
The US Food and Drug Administration (FDA) has awarded Breakthrough Device Designation to Thermedical for Saline Enhanced Radiofrequency (SERF) ablation system and Durablate catheter.
Novartis expands ophthalmology pipeline with Amblyotech acquisition
Novartis has acquired US-based software startup Amblyotech, which is developing a digital treatment for amblyopia (lazy eye) that leads to vision loss in children and young adults.
Read our magazine
Medical Technology is the essential reading material for decision-makers in the medical device industry, bringing you the latest news and analysis in an exciting, interactive format.